Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 2 days, don't miss out!

De La Rue

January 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • DLAR
  • Price:
  • 147p
The highlight of De La Rue’s interim results for the period ended September was the 13.7% increase in operating profit to £17.4m on sales up 10.3% to £177.1m. Delayed phasing of capital investment and strong cash management reduced net debt from £52.3m to £43.9m.The currency division increased sales 5% to £132.7m driven by ongoing global demand for cash and a greater contribution from more durable polymer bank notes, where a second production line will be operational in H2. Encouragingly, management expect 100% utilisation of manufacturing capacity in H2 while the “cost out” program is virtually completed with a further £7m savings to be recognised in H2.Within Authenticat ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X